Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Frequency and Type-distribution of Human Papillomavirus from Paraffin-embedded Blocks of High Grade Cervical Intraepithelial Neoplasia Lesions in Thailand

  • Published : 2013.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Cervical cancer is the most important female gynecological cancer, the second leading cause of cancer mortality in women worldwide and the second most common cancer in Thai women. The major cause of cervical cancer is persistent infection of human papillomavirus (HPV), leading to abnormal epithelial lesions, with progression to precancerous and invasive cancer. This study was conducted to investigate the frequency and type distribution of HPV in Thai women who had abnormal cytology. HPV detection from FFPE confirmed abnormal of high grade cervical intraepithelial lesions were for SPF-10-Innogenic Line Probe Assay. HPV-positivity was detected in 320/355 cases (90.14%) and HPV-negativity in 35/355 (9.86%). HPV-positive was found 147/320 cases (41.4%) of single infection, whereas 173/320 cases (48.7%) showed the multiple HPV infection. The most common seven types were HPV-16, -52, -18, -11, -51, -31 and -33, in that order. HPV 16 and 18, the important oncogenic HPV type, were observed in 64.8% of HSIL cases. Interestingly, a high proportion of multiple infections was found in this study and more than ten types could be detected in one case. Therefore, HPV infection screening program in women is essential, particularly in Thailand. Effective primary and secondary prevention campaigns that reinforce HPV screening for HPV detection and typing may be decrease the incidence and mortality of cervical cancer in the future and may lead to significantly improve the quality of life in Thai women.

Keywords

References

  1. Bello BD, Spinillo A, Alberizzi P, et al (2009). Validation of the SPF10 LiPA human papillomavirus typing assay using formalin-fixed paraffin-embedded cervical biopsy samples. J Clin Microbiol, 47, 2175-80. https://doi.org/10.1128/JCM.00286-09
  2. Bharti AC, Shukla S, Mahata S, et al (2010). Human papillomavirus and control of cervical cancer in India. Expert Rev Obstet Gynecol, 5, 329-46. https://doi.org/10.1586/eog.10.23
  3. Bhatla N, Lal N, Bao YP, et al (2008). A meta-analysis of human papillomavirus type-distribution in women form South Asia: Implication for vaccination. Vaccine, 26, 2811-7. https://doi.org/10.1016/j.vaccine.2008.03.047
  4. Ciapponi A, Bardach A, Glujovsky D, et al (2011). Type-specific hpv prevalence in cervical cancer and high-grade lesion in latin america and the caribbean: systematic review and meta-analysis. PLOS one,6, 1-15.
  5. Characterization of human papillomavirus type 16 from infected Thai women with different cytological finding. Virus Genes, 39, 30-8.
  6. Correnti M, Medina F, Cavazza ME, et al (2011). Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesion in Venezuelan women. Gynecologic Oncol,121, 517-31.
  7. Dowhanick JJ, McBride AA, Howley PM (1995). Suppression of cellular proliferation by the papillomavirus E2 protein, J Virol, 69, 7791-9.
  8. Gravitt PE, van Doorn LJ, Quint W, et al (2007). Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions. J Clin Microbiol, 45, 3245-50. https://doi.org/10.1128/JCM.00216-07
  9. Human Papillomavirus Typing Assay Using Formalin-Fixed Paraffin-Embedded Cervical Biopsy Samples. J Clin Microbiol, 47, 2175-80.
  10. International Agency for Research on Cancer (1995). IARC Monograph on the Evaluation of Carcinogenic Risks to Human, Vol 64. Human papillomavius. IARC, Lyon.
  11. Jacob MV, van den Brule AJ, Snijder PJ, et al (1996). A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV16 and 18 in cervical scrapes after GP5+/6+ PCR. J Med Virol , 49, 223-9. https://doi.org/10.1002/(SICI)1096-9071(199607)49:3<223::AID-JMV11>3.0.CO;2-D
  12. Lurchachaiwong W, Junyangdikul P, Payungporn S, et al (2009). Entire genome.
  13. Mateos Lindemann ML, Sanchez Calvo JM, Chacon de Antonio J, et al (2011). Prevalence and distribution of high-risk genotypes of hpv in women with severe cervical lesion in madrid, spain: importance of detecting genotype 16 and other high-risk genotypes. Adv Prev Med, 10,2011.
  14. Munoz N (2000). Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol, 19, 1-5. https://doi.org/10.1016/S1386-6532(00)00125-6
  15. Ramet J, van Esso D, Meszner Z (2011). Positive paper- HPV and the primary prevention of cancer; improving vaccine uptake by paediatricians. Eur J Pediatr, 170, 309-21. https://doi.org/10.1007/s00431-010-1265-9
  16. Van Hamont D, van Ham MA, Bakkers JM, et al (2006). Evaluation of the SPF-10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test. J Clin Microbiol, 449, 3122-9.
  17. Villiers EM, Fanquet C, Broker TR, et al (2004). Classification of papilloma-virus. Virology, 324, 17-27. https://doi.org/10.1016/j.virol.2004.03.033
  18. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer world-wide. J Pathol, 189, 12-9. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
  19. World Health Organization (2010). Human paillomavirus Laboratory Manual. 1st ed. HPV Laboratory Network, WHO: Switzerland.
  20. Zur Hausen H (2002). Papillomavirus and cancer: from basic studies to clinical application. Nature Rev, 2, 342-50. https://doi.org/10.1038/nrc798

Cited by

  1. Human Papillomavirus Genotypes Profile in Cervical Cancer Patients at Dr. Hasan Sadikin General Hospital, Bandung, Indonesia vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5781
  2. Prevalence of High Risk Human Papillomavirus Infection with Different Cervical Cytological Features among Women Undergoing Health Examination at the National Cancer Institute, Thailand vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5879
  3. Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Cancer Risk in a Nested Case-Control Study in North-East Thailand vol.15, pp.3, 2014, https://doi.org/10.7314/APJCP.2014.15.3.1497
  4. HPV Detection and Genotyping in Vulvar Squamous Cell Carcinoma in Northern Thailand vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3773
  5. CD24 promotes the proliferation and inhibits the apoptosis of cervical cancer cells in vitro vol.35, pp.3, 2016, https://doi.org/10.3892/or.2015.4521
  6. Molecular Genotyping of Human Papillomavirus L1 Gene in Low-Risk and High-Risk Populations in Bangkok vol.42, pp.4, 2015, https://doi.org/10.1097/OLQ.0000000000000259
  7. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand vol.88, pp.1, 2015, https://doi.org/10.1002/jmv.24290